+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "CGMP"

From
Peptide and Oligonucleotide CDMO Market Report 2025 - Product Thumbnail Image

Peptide and Oligonucleotide CDMO Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Pharmaceutical Continuous Manufacturing Market Report 2025 - Product Thumbnail Image

Pharmaceutical Continuous Manufacturing Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
FDA Enforcement Manual - Online - Product Thumbnail Image

FDA Enforcement Manual - Online

  • Directory
  • April 2025
  • Global
Process Validation for Pharmaceutical and Biologics (Recorded) - Product Thumbnail Image

Process Validation for Pharmaceutical and Biologics (Recorded)

  • Training
  • February 2025
  • 2 Days
  • Global
From
Loading Indicator

The CGMP market is a subset of the pharmaceutical manufacturing industry, focusing on the production of drugs and other pharmaceutical products in accordance with Current Good Manufacturing Practices (CGMP). CGMPs are a set of regulations and guidelines issued by the US Food and Drug Administration (FDA) to ensure that pharmaceutical products are safe and effective. CGMPs cover all aspects of the manufacturing process, from raw materials to finished products, and include requirements for quality control, personnel training, and record keeping. The CGMP market is highly competitive, with many large and small companies offering a variety of services. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies in the market include Teva Pharmaceuticals, AstraZeneca, Bayer, and Eli Lilly. Show Less Read more